Hikma Pharmaceutical | HIK - Interest Income


Hikma Pharmaceutical reported $4M in Interest Income for its fiscal semester ending in December of 2024.





Interest Income Change Date
Almirall EUR 2.71M 580K Dec/2025
argenx SE USD 44.87M 2.17M Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Autolus Therapeutics Ltd USD 6.14M 1.31M Mar/2025
Bayer EUR 169M 39M Dec/2025
Genmab DKK 25M 8M Jun/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck EUR 21M 6M Dec/2025
Sanofi EUR 33M 81M Dec/2025